Rice is a main food staple in many cultures, but it can cause glucose spikes for people with diabetes. From rice alternatives to smaller portions, here are some ways to...

Free software upgrade for t:slim X2 users, first G5-integrated pump on the market, CGM can be used for insulin dosing and remote monitoring

By Jimmy McDermott and Maeve Serino FreeStyle LibreLink app allows FreeStyle Libre users in the US to obtain a real-time glucose reading directly on their iPhone. Plus,...

A recent consensus report from leading experts details a new definition for what it means to have type 2 diabetes in remission and why it is important to use the proper...

Kelly laments the FDA's latest disappointing decision and extends a personal invitation to celebrate World Diabetes Day with the diaTribe team .

The FDA’s decision on Bydureon was a shocker. We break down this decision and discuss why we view it as such a disappointment.

Medical technology manufacturer Valeritas announced earlier this month that it received FDA clearance to market its V-Go Disposable Insulin Delivery Device, which...

In early November, Kombiglyze, a pill combining DPP-4 inhibitor Onglyza and metformin, was approved by the FDA for type 2 diabetes. Onglyza was approved in July 2010...

In a major setback for MannKind Corporation ’s inhalable insulin therapy, Afrezza, the FDA is requiring the company to conduct two additional clinical trials of the...

Earlier this month, the FDA approved the once-daily oral drug Tradjenta (Boehringer Ingelheim and Eli Lilly’s linagliptin) for type 2 diabetes. Tradjenta belongs to the...

D. Medical's Spring Universal Infusion Set has been cleared by the FDA. After almost 18 months of review at the FDA, D. Medical’s subsidiary Spring-Set Health Solutions...

In mid-April, the European Medicine Agency's Committee for Medicinal Products for Human Use (a committee called the "CHMP") recommended that Amylin/Lilly/Alkermes' once-...

On June 16, FDA officials provided an update on its safety review of Takeda’s Actos (pioglitazone), announcing that going forward, prescribing information for Actos will...

According to a recent Apple report , over 425,000 mobile apps are now available in the App Store, with a staggering 200 million users and 15 billion downloads. And...

In late March, the International Diabetes Federation (IDF) released a "position statement" recommending the consideration of bariatric surgery to treat type 2 diabetes...

In June, First Lady Michelle Obama and Walt Disney CEO Robert Iger announced a bold new plan to ban commercials and advertisements for unhealthy food products targeted...

On July 17, the FDA approved Vivus’ weight-loss medication Qsymia (formerly called Qnexa), just several weeks after the approval of Arena’s Belviq (see new now next in...

On November 8, an FDA advisory panel voted 8-4 to recommend approval of Novo Nordisk’s ultra-long-acting basal insulin degludec (to be marketed under the name “Tresiba...

On February 27, the FDA published proposed regulations to update nutrition fact labels that would make the familiar labels undergo a dramatic change for the first time...

On April 3, an FDA Advisory Committee voted an overwhelming 13-1 in favor of approving MannKind’s ultra-rapid-acting inhaled insulin Afrezza for type 1 diabetes. The...